Summary:
A 52 week, multicenter study to assess the time course of response to secukinumab on joint inflammation using Power Dopple ultrasonography in patients with active psoriatic arthritis.
Qualified Participants Must:
• Male and Female
• 18+
•
Active Psoriasis for at least 6 months
•
Tender joints
•
Swollen joints
• Inadequate response to non-biologic DMARDs
Qualified Participants May Receive:
Participants who meet all of the Inclusion/ Exclusion criteria will receive up tp $60 per visit.